Todd Hauser, Co-Founder & CEO, explains how TrilliumAg uses RNAi technology to unlock a new era of biological crop protection products

RNAi was discovered more than 20 years ago and has been used by the pharmaceutical industry to develop a host of novel medicines. TrilliumAg’s research team has found a way to develop biological solutions that target specific pests.